TEVA Related Insiders' Blog
-
Flooded Generic Market Mutes Growth Potential for Teva Pharma (TEVA) - Cramer
-
Investors Scoff At Teva's (TEVA) Cost Cutting Plans
-
Amarin (AMRN) Higher as Teva (TEVA) Said to be Waiting in the Wings for a Takeover
-
Elan (ELN), Novartis (NVS) Tick Higher on PDUFA Extension for Biogen's (BIIB) MS PillBG-12
-
Watson Pharma (WPI) May Pay $6B for Mysterious Swiss Drug Maker
-
Novartis (NVS) Could Formulate Strong Results in 2012 - Barron's
-
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
-
Teva (TEVA) Investors Like CEO Succession Plan, Shares Move Higher
-
Teva (TEVA) Continues Early Weakness Following FY12 Outlook
-
Pfizer (PFE) May Get Several More Months of Lipitor Exclusivity
-
Teva (TEVA) May Be One of the Cheapest Pharmas Right Now - Barron's
-
Teva (TEVA) Getting Dose of Own Medicine in Copaxone Challenge
-
Momenta (MNTA) Blood Thinner Could Thicken Your Portfolio - Barron's
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Drug Makers Higher On Health Care Reform (PFE, MRK, TEVA, more...)
-
Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
-
Top 15 For 2008 (No. 14): M&A Wreckage
-
Gates' The Bill and Melinda Gates Foundation Shows New Positions in Crocs (CROX), Dick's (DKS) and Raised Stakes in McDonald's (MCD), FedEx (FDX) and AIG (AIG)
-
Summary of Jana Partners 13F; New Stakes in AA, APC, BEAS, CNET, Ups Stake in YHOO
-
Wyeth (WYE) Hits New 52-Week Low on Generic Protonix News
Back to TEVA Stock Lookup
